Business Description
Diagonal Bio AB
ISIN : SE0015961826
Share Class Description:
OSTO:DIABIO: Ordinary SharesCompare
Compare
Traded in other countries / regions
DIABIO.Sweden9F1.Germany IPO Date
2021-07-16Description
Diagonal Bio AB is developing a diagnostic platform for ultra-rapid, parallel, accurate and cost-efficient detection of any kind of pathogen - Panviral.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -0.46 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | -2.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.32 | |||||
| 9-Day RSI | 45.87 | |||||
| 14-Day RSI | 47.71 | |||||
| 6-1 Month Momentum % | 6.19 | |||||
| 12-1 Month Momentum % | -85.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | |||||
| Quick Ratio | 1.72 | |||||
| Cash Ratio | 1.47 | |||||
| Days Sales Outstanding | 365 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -37 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 7869.57 | |||||
| Operating Margin % | -47447.83 | |||||
| Net Margin % | -50504.35 | |||||
| FCF Margin % | -45878.26 | |||||
| ROE % | -49.95 | |||||
| ROA % | -39.49 | |||||
| ROIC % | -41.1 | |||||
| ROC (Joel Greenblatt) % | -10384.65 | |||||
| ROCE % | -46.56 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 32 | |||||
| PB Ratio | 0.44 | |||||
| Price-to-Tangible-Book | 3.2 | |||||
| Price-to-Free-Cash-Flow | 0.74 | |||||
| Price-to-Operating-Cash-Flow | 0.74 | |||||
| EV-to-EBIT | -0.81 | |||||
| EV-to-EBITDA | -0.84 | |||||
| EV-to-Revenue | 376.73 | |||||
| EV-to-FCF | -0.86 | |||||
| Price-to-Net-Current-Asset-Value | 3.2 | |||||
| Earnings Yield (Greenblatt) % | -124.56 | |||||
| FCF Yield % | -82.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Diagonal Bio AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 0.023 | ||
| EPS (TTM) (kr) | -0.138 | ||
| Beta | -2.67 | ||
| Volatility % | 430.35 | ||
| 14-Day RSI | 47.71 | ||
| 14-Day ATR (kr) | 0.005191 | ||
| 20-Day SMA (kr) | 0.033865 | ||
| 12-1 Month Momentum % | -85.15 | ||
| 52-Week Range (kr) | 0.0063 - 0.369671 | ||
| Shares Outstanding (Mil) | 400.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Diagonal Bio AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Diagonal Bio AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Diagonal Bio AB Frequently Asked Questions
What is Diagonal Bio AB(OSTO:DIABIO)'s stock price today?
The current price of OSTO:DIABIO is kr0.03. The 52 week high of OSTO:DIABIO is kr0.37 and 52 week low is kr0.01.
When is next earnings date of Diagonal Bio AB(OSTO:DIABIO)?
The next earnings date of Diagonal Bio AB(OSTO:DIABIO) is 2025-02-25.
Does Diagonal Bio AB(OSTO:DIABIO) pay dividends? If so, how much?
Diagonal Bio AB(OSTO:DIABIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers